Vitamin D receptor gene Tru9I polymorphism and risk for incidental sporadic colorectal adenomas

AIM: Recent laboratory and epidemiological studies suggest that vitamin D is a potential agent for colorectal cancer prevention. Its function is partially mediated by the vitamin D receptor (VDR). The aim of this study was to investigate whether a novel G (allele ‘U’g〉A (allele ‘u’ polymorphism (Tru...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 11; no. 31; pp. 4794 - 4799
Main Authors Gong, You-Ling, Xie, Da-Wen, Deng, Zong-Lin, Bostick, Roberd M, Miao, Xi-Jiang, Zhang, Jin-Hui, Gong, Zhi-Hong
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 21.08.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:AIM: Recent laboratory and epidemiological studies suggest that vitamin D is a potential agent for colorectal cancer prevention. Its function is partially mediated by the vitamin D receptor (VDR). The aim of this study was to investigate whether a novel G (allele ‘U’g〉A (allele ‘u’ polymorphism (Tru9I) in the VDR intron 8 region is associated with risk for colorectal adenoma in a colonoscopy-based case-control study. METHODS: Genotyping for a total of 391 subjects was carried out through PCR and restriction fragment length polymorphism. RESULTS: The frequencies of ‘U’ and ‘u’ alleles were 89.3% and 10.7%, respectively. The ‘Uu’ and ‘uu’ genotypes were associated with decreased risk for adenoma (OR, 0.71; 95%CI, 0.40-1.25). The inverse association was more pronounced for multiple adenomas and adenomas that were larger had moderate or greater dysplasia, or were sessile: the odds ratios (ORs) were, 0.51 (95%CI, 0.21-1.24), 0.37 (95%CI, 0.11-1.28), 0.68 (95%CI, 0.33- 1.41), and 0.36 (95%CI, 0.13-0.97) respectively. In joint/ combined analyses, inverse associations were more obvious among those who had at least one ‘u’ allele and also were younger (OR, 0.60; 95%CI, 0.26-1.37), women (OR, 0.38; 95%CI, 0.17-0.88), did not smoke (OR, 0.39; 95%CI, 0.13-1.23), or took NSAID (OR, 0.38; 95%CI, 0.12-1.25), but no evidence existed for interactions with calcium or vitamin D intake.CONCLUSION: Our findings suggest that the VDR TrugI polymorphism may be associated with lower risk for colorectal adenoma, particularly in interaction with various risk factors, but not with calcium or vitamin D.
Bibliography:R735.3
Colorectal adenoma
14-1219/R
Vitamin D receptor
Case-control study; Colorectal adenoma;Colorectal neoplasia; Vitamin D receptor; Genetic polymorphism
Genetic polymorphism
Case-control study
Colorectal neoplasia
Telephone: +01-803-434-3707 Fax: +01-803-434-3795
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Da-Wen Xie, University of South Carolina, 14 Richland Medical Park, Suite 500, Columbia, SC 29203, USA. dawen.xie@palmettohealth.org
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v11.i31.4794